follicle stimulating hormone has been researched along with menotropins in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Marshall, DC; Raike, E; Scobey, MJ | 1 |
Blake, EJ; Doody, KJ; Foulk, RA; Kolb, BA; Miller, CE; Schnell, VL; Yankov, VI | 1 |
Aydin, NE; Celik, O; Hascalik, S; Tagluk, ME; Yildirim, A | 1 |
Akira, S; Inagawa, T; Katayama, A; Kuwabara, Y; Mine, K; Takeshita, T | 1 |
Antaki, R; Benoit, J; Bissonnette, F; Dean, NL; Kadoch, IJ; Lapensée, L; Lefebvre, J; Ménard, S; Sylvestre, C | 1 |
Candela, FA; Carnevali, O; Ciavattini, A; Cignitti, M; Gioacchini, G; Giorgini, E; Montik, N; Notarstefano, V; Polidori, AR; Vaccari, L | 1 |
2 trial(s) available for follicle stimulating hormone and menotropins
Article | Year |
---|---|
Endometrin for luteal phase support in a randomized, controlled, open-label, prospective in-vitro fertilization trial using a combination of Menopur and Bravelle for controlled ovarian hyperstimulation.
Topics: Adolescent; Adult; Drug Combinations; Female; Fertility Agents, Female; Fertilization in Vitro; Humans; Intrauterine Devices, Medicated; Luteal Phase; Menotropins; Ovulation Induction; Pregnancy; Pregnancy Rate; Progesterone; Single-Blind Method; Treatment Outcome; Urofollitropin; Young Adult | 2009 |
450 IU versus 600 IU gonadotropin for controlled ovarian stimulation in poor responders: a randomized controlled trial.
Topics: Adult; Embryo Implantation; Embryo Transfer; Female; Fertility Agents, Female; Fertilization in Vitro; Follicle Stimulating Hormone; Humans; Infertility; Menotropins; Oocyte Retrieval; Ovary; Ovulation; Ovulation Induction; Pregnancy; Pregnancy Rate; Prospective Studies; Quebec; Sperm Injections, Intracytoplasmic; Treatment Outcome; Urofollitropin | 2015 |
4 other study(ies) available for follicle stimulating hormone and menotropins
Article | Year |
---|---|
Mixed protocols: multiple ratios of FSH and LH bioactivity using highly purified, human-derived FSH (BRAVELLE) and highly purified hMG (MENOPUR) are unaltered by mixing together in the same syringe.
Topics: Animals; Biological Assay; Biological Availability; Drug Combinations; Female; Male; Menotropins; Ovulation Induction; Rats; Rats, Sprague-Dawley; Rats, Wistar; Syringes; Urofollitropin | 2005 |
Effects of highly purified urinary FSH and human menopausal FSH on uterine myoelectrical dynamics.
Topics: Animals; Electrophysiology; Female; Follicle Stimulating Hormone; Humans; Menotropins; Myometrium; Ovariectomy; Rats; Rats, Wistar; Urofollitropin | 2010 |
Proteomic analyses of recombinant human follicle-stimulating hormone and urinary-derived gonadotropin preparations.
Topics: Electrophoresis, Gel, Two-Dimensional; Female; Follicle Stimulating Hormone, beta Subunit; Glycoprotein Hormones, alpha Subunit; Humans; Mass Spectrometry; Menotropins; Recombinant Proteins; Urofollitropin | 2009 |
The Impact of Controlled Ovarian Stimulation Hormones on the Metabolic State and Endocannabinoid System of Human Cumulus Cells.
Topics: Adult; Arachidonic Acids; Cells, Cultured; Cohort Studies; Cumulus Cells; Endocannabinoids; Female; Follicle Stimulating Hormone, Human; Gene Expression; Humans; Menotropins; Oocyte Retrieval; Ovulation Induction; Polyunsaturated Alkamides; Recombinant Proteins; Signal Transduction; Spectroscopy, Fourier Transform Infrared; Urofollitropin | 2020 |